Dear PKUers,
Sino-American Biomedical and Pharmaceutical Professionals Association (SABPA) is organizing a BioMedical Forum on March 28 at UCI <http://www.sabpa.org/web/news_details.php?ID=157>. It is a very good opportunity to meet people and build contacts in pharmaceutical and medical device industry.
Best regards,
PUAASC
--------------------------------------------------------------
4th Annual Biomedical Forum
Date: March 28, 2009 (Saturday)
Location: McDonald Douglass Auditorium, UC Irvine
Registration (Lunch included): $30 for pre-registration (before March 14), $15 for students and post-docs, $40 for onsite registration
Online Registration: http://www.sabpa.org/web/news_details.php?ID=157
Program
Mitchell Brin, M.D.
Senior Vice President, Global Drug Development & Chief Scientific Officer, Allergan, LLC. & Clinical Professor of Neurology, University of California,
“Discovery And Development of Botox”
David Ke, M.D.
Executive Scientific Director, Amgen, Inc.
“Transforming Basic Science To Drug Discovery: The Story Of Sclerosteosis And Development Of Anti-Sclerostin Monoclonal Antibody”
James Shen Ph.D.
Import Compliance Officer, FDA
“Requirements Of Laws And Regulations Enforced By FDA Concerning Medical And Pharmaceutical Products”
Stan Rowe
Chief Scientific Officer, Corporate Vice President, Edwards Lifesciences LLC
“Practical Innovations in Cardiac Disease Management”
Peter Chen, Ph.D.
President, Center for Innovation and Strategic Collaboration, St. Jude Medical, Inc.
“Innovations in Cardiac Rhythm Management and Neuromodulation Devices”
Rob Michiels
Chief Operating Officer, CoreValve Inc.
“Transformation in Heart Valve Replacement”
Sofie Qiao, Ph.D.
Founder, Senior VP,Director of Chinese Operations, Lead Therapeutics, Inc
"The Long LEAD to Venture Funding"
Daren Chen
Hillcrest Venture Partners, A New Lifescience Venture Fund.
“Investment Criteria in the New Global Economy”
Yuwen Liu
General Manager, Biobay, Suzhou Industrial Park.
“Biomedical Technology Investment and Entrepreneurs in Suzhou, China”